期刊文献+

ABCA_1基因多态性R219K与脂代谢及急性心肌梗死易感性的相关性 被引量:1

Correlation of polymorphism of R219K in ABCA_1 with lipid metabolism and the risk of AMI
下载PDF
导出
摘要 目的通过对男性急性心肌梗死患者在三磷酸腺苷结合盒转运子A(ABCA1)基因多态性R219K的研究,寻找ABCA1多态性与急性心梗发生率的相关性。方法利用限制片长——多态性方法检测49例急性心肌梗死患者及72例对照组R219K单核苷酸多态性的相关性。结果急性心肌梗死组ABCA1基因219K等位基因显著低于对照组(P<0.001),且急性心肌梗死组219K等位基因携带者HDL水平显著高于非219K等位基因携带者(P<0.05),TG水平明显低于非K携带者(P<0.05)。结论ABCA1基因R219K多态性中,K等位基因可影响患者HDL:及TG水平,进而影响急性心梗发生率。 Objective To study the correlation of ATP binding cassette transporter A1 ( ABCA1 ) and the gene polymorphism of R219K in male patients with acute myocardiac infarction (AMI), and to find the association of ATP binding cassette transporter A1 gene R219K common variant with the risk of AMI. Methods The association of the gene polymorphism of R219K in 49 cases with AMI (test group) and 72 cases (control group) were detected by restriction fragment length polymorphism (RFLP) and polymerase chain reaction(PCR). Results The 219K site genotype of ABCA1 gene in AMI patients was obviously lower than that in control group( P 〈 0. 001 ), and high density lipoprotein (HDL) in allel K carders was obviously higher than non-allel K carriers ( P 〈 0.05 ). Triglyeride (TG) was obviously less than in non-allel K carders (P 〈0.05 ). Conclusion Polymorphism of R219K in ABCA1 is concerned with AMI and HDL cholesterol and TG metabolism.
作者 余斌 邓兵
出处 《同济大学学报(医学版)》 CAS 2008年第5期64-67,共4页 Journal of Tongji University(Medical Science)
关键词 ABCA1基因R219K多态性 心肌梗死 血脂 polymorphism of R219K in ATP binding cassette transporter A1 acute myocardiac infarction blood lipid
  • 相关文献

参考文献10

  • 1Lin G, Oram JF. Apolipoprotein binding to protruding membrane domains during removel of excess cellular cholesterol [ J ]. Athorosclerosis, 2000,149 : 359 - 370.
  • 2Tanne D, Yaari S, Goldbourt U. Isolated low HDd cholesterol as a risk factor for coronary heart disease mortality: a 21 year follow up of 8000 men [ J ]. Arterioscler Thromb Vase Bid, 1997,17 : 103 - 113.
  • 3Repa J J, Turley SD, Lobaccare JMA, et al. Regulation of absorption and ABCA1 mediated efflux of cholesterol by RXR heterodimers[J]. Science ,2000,89 : 152.
  • 4Clee SM, Zwindeman AH, Engert JC, et al. Common genetic Variation in ABCA1 is associated with altered lipoprotein levels and a modified risk for cororary artery disease [J]. Circulation ,2001,103 : 1198 - 1205.
  • 5Bodzioch M, Orso E, Klucken J, et al. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease [J]. Nat Genet, 1999,22:347 - 351.
  • 6Brousseau ME, Eberhart GP, Dupuis J, et al. Cellular cholesterol efflux in heterozygotes for tangier disease is markedly reduced and correlates with high density lipoprotein cholesterol concentration and particle size [J]. J Lipid Res,2000,41:1125 - 1135.
  • 7Rust S, Rosier M, Funke H, et al. Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter[ J]. Nat Genet, 1999,22:352 - 355.
  • 8孙屏,李晓宇,郭冬平,陈琪,范乐明.三磷酸腺苷结合盒转运子A1基因多态性R219K与脂代谢及冠心病易感性的相关性[J].中国动脉硬化杂志,2005,13(1):13-16. 被引量:11
  • 9Lawn RM, Wade DP, Garvin MR, et al. The Tangier disease gene product ABC, controls the cellular apolipoprotein-mediated lipid removal pathway [ J ]. Clin Invest, 1999,104 : R25 - R31.
  • 10曾武威,陈保生.胆固醇酯转运蛋白与动脉粥样硬化的关系[J].中国动脉硬化杂志,2002,10(3):262-264. 被引量:19

二级参考文献30

  • 1[1]Hirano K, Yamashita S, Matsuzawa Y. Pros and cons of inhibiting cholesteryl eater transfer protein. Curr Opin in Lipidology, 2000, 11: 589-596
  • 2[2]Agellon L, Quinet E, Gillette T, et al. Organization of the human cholesteryl ester transfer protein gene. Biochemistry, 1990, 29: 1 372-376
  • 3[3]Bruce C, Chouinard RA, Tall AR. Plasma lipid transfer proteins, high-density lipoproteins, and reverse cholesterol transport. Annu Rev Nutr, 1998, 18: 297-330
  • 4[4]Connolly DT, Heuvelman D, Glenn K. Inactivation of cholesteryl ester transfer protein by cysteine modification. Biochem Biophys Res Commun, 1996, 223: 42-47
  • 5[5]Huuskonen J, Olkkonen VM, Jauhiainen M, et al. The impact of phospholipid transfer protein (PLTP) on HDL metabolism. Atherosclerosis, 2001, 155 (2): 269-81
  • 6[6]Stevenson SC, Wang S, Deng L, et al. Human plasma cholesteryl ester transfer protein consists of a mixture of two forms reflecting variable glycosylation at asparagine 341. Biochemistry, 1993, 32: 5 121-126
  • 7[7]Oliveira HCF, Chouinard RA, Agellon LB, et al. Human cholesteryl ester transfer protein gene proximal promoter contains dietary cholesterol positive responsive elements and mediates expression in small intestine and periphery while predominant liver and spleen expression is controlled by 5'-distal sequences; cis-acting sequences mapped in transgenic mice. J Biol Chem, 1996, 271: 31 831-838
  • 8[8]Quinet E, Yang TP, Marinos C, et al. Inhibition of the cellular secretion of cholesteryl ester transfer protein by a variant protein formed by alternative splicing of mRNA. J Biol Chem, 1993, 268: 16 891-894
  • 9[9]Quinet E, Tall A, Ramakrishnan R, et al. Plasma lipid transfer protein as a determinant of the atherogenicity of monkey plasma lipoproteins. J Clin Invest, 1991, 87: 1 559-566
  • 10[10]Marotti KR, Castle CK, Boyle TP, et al. Severe atherosclerosis in transgenic mice expressing simian cholesteryl ester transfer protein. Nature, 1993, 364: 73-75

共引文献27

同被引文献7

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部